VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VTR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VTRVentas, Inc.
$94.07$44.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

VTR logoVentas, Inc.(VTR)Earnings, Financials & Key Ratios

VTR•NYSE•REIT / Real Estate
$92.21
170.8× P/E·Price updated Jul 6, 2026
SectorReal EstateIndustryHealthcare REITsSub-IndustryDiversified healthcare real estate
AboutVentas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.Show more
  • Revenue$5.83B+18.5%
  • FFO$1.63B+19.5%
  • FFO/Share3.52+7.6%
  • FFO Payout52.75%-2.8%
  • FFO per Share3.52+7.6%
  • NOI Margin-5.9%-113.9%
  • FFO Margin27.95%+0.9%
  • ROE2.15%+169.5%
  • ROA0.93%+193.3%

VTR Price & Volume

Ventas, Inc. (VTR) stock price & volume — 10-year historical chart

Loading chart...

Ventas Accelerates Revenue Growth Amid Operational Volatility

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Accelerating
Profitability:Moderate
Financial:Healthy
Cash Flow:Improving
Primary Risk:SHOP segment operational volatility

Key Thesis Takeaways

  • Ventas is currently benefiting from a robust 22.0% year-over-year revenue expansion driven by the recovery of its Senior Housing Operating Portfolio, though investors should remain cautious regarding the sustainability of these gains given the fluctuation in NOI margins to 39.6% in 2026Q1.
  • While the company maintains a healthy dividend payout ratio relative to AFFO of approximately 0.51 to 0.56, the divergence between GAAP net income and FFO, alongside potential reporting discrepancies in debt levels, necessitates a disciplined approach to valuation.
  • Future performance will likely hinge on the company's ability to manage labor-related cost pressures while effectively deploying capital from its $183.6 million cash position.

Verdict Logic

while the 16.7% FFO growth in 2026Q1 is encouraging, the significant accounting anomalies, such as the -$2.1B NOI reported in 2025Q4, suggest that investors should wait for greater transparency in financial reporting.

VTR Growth Metrics

Ventas, Inc. (VTR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years5.91%
5 Years8.98%
3 Years12.21%
TTM20.67%

Profit CAGR

10 Years-4.95%
5 Years-10.56%
3 Years-
TTM82.97%

EPS CAGR

10 Years-8.05%
5 Years-14.33%
3 Years-
TTM65.17%

Return on Capital

10 Years2.79%
5 Years2.36%
3 Years2.62%
Last Year3.24%

VTR Recent Earnings

Ventas, Inc. (VTR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Apr 27, 2026
Metric
Actual
Est
EPS
$0.12-2.4%
$0.12
Rev
$1.7B+4.5%
$1.6B
Q1 2026
Feb 5, 2026
Metric
Actual
Est
EPS
$0.15+49.0%
$0.10
Rev
$1.6B+4.1%
$1.5B
Q4 2025
Oct 29, 2025
Metric
Actual
Est
EPS
$0.88+1.1%
$0.87
Rev
$1.5B-2.8%
$1.5B
Q3 2025
Jul 30, 2025
Metric
Actual
Est
EPS
$0.87+2.4%
$0.85
Rev
$1.4B+1.1%
$1.4B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 27, 2026
$0.12vs $0.12-2.4%
$1.7Bvs $1.6B+4.5%
Q1 2026Feb 5, 2026
$0.15vs $0.10+49.0%
$1.6Bvs $1.5B+4.1%
Q4 2025Oct 29, 2025
$0.88vs $0.87+1.1%
$1.5Bvs $1.5B-2.8%
Q3 2025Jul 30, 2025
$0.87vs $0.85+2.4%
$1.4Bvs $1.4B+1.1%
Based on last 12 quarters of dataView full earnings history →

Latest VTR News

Recent stock market news and headlines for Ventas, Inc. (VTR)

Business Wire·Jun 29, 2026
Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its second quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 29, 2026. A conference call to discuss those earnings will be held on Thursday, July 30, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can b.

Zacks Investment Research·Jun 25, 2026
Is Holding Ventas Stock Still a Smart Move for Your Portfolio Now?

VTR benefits from strong senior housing demand, rising occupancy and solid liquidity but faces competition, tenant concentration and high debt.

Business Wire·Jun 22, 2026
Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that the Company has named Andrew L. Wattula Executive Vice President, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, a wholly-owned property management and leasing subsidiary of Ventas, effective August 2026. He will oversee the Company's differentiated outpatient medical and research business, which is a leading owner and manager of properties operating at the intersec.

Peers Comparison

Key metrics vs top competitors for Ventas, Inc. (VTR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
VTR logoVTRVentas, Inc.Current
$92.21$43.84B170.7618.47%4.31%2.15%2.02%
WELL logoWELLWelltower Inc.
$232.69$163.03B167.4035.82%12.31%3.49%—
HR logoHRHealthcare Realty Trust Incorporated
$20.40$7.12B-28.73-6.92%-17.51%-4.28%—
OHI logoOHIOmega Healthcare Investors, Inc.
$49.02$14.6B25.2713.95%51.02%11.85%—
SBRA logoSBRASabra Health Care REIT, Inc.
$19.73$4.98B30.8310.15%19.21%5.6%—
NHI logoNHINational Health Investors, Inc.
$76.00$3.68B25.1712.93%36.76%9.78%—

Compare VTR vs Peers

Ventas, Inc. (VTR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs WELL

Most directly comparable listed peer for VTR.

Scale Benchmark

vs SPG

Larger-name benchmark to compare VTR against a more recognizable public peer.

Peer Set

Compare Top 5

vs WELL, HR, OHI, SBRA

VTR SEC Filings & Documents

Ventas, Inc. (VTR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 27, 2026·SEC

Material company update

Feb 20, 2026·SEC

Material company update

Feb 9, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 6, 2026·SEC

FY 2025

Feb 13, 2025·SEC

10-Q Quarterly Reports

5
FY 2026

Apr 28, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

Get notified when VTR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

VTR Frequently Asked Questions

Ventas, Inc. (VTR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Ventas, Inc.'s revenue?

Ventas, Inc. (VTR) reported $6.13B in revenue for fiscal year 2025. This represents a 138% increase from $2.58B in 1996.

How fast is Ventas, Inc. growing?

Ventas, Inc. (VTR) grew revenue by 18.5% over the past year. This is strong growth.

Is VTR profitable?

Yes, Ventas, Inc. (VTR) is profitable, generating $260.4M in net income for fiscal year 2025 (4.3% net margin).

Dividend & Returns
Does VTR pay dividends?

Yes, Ventas, Inc. (VTR) pays a dividend with a yield of 2.02%. This makes it attractive for income-focused investors.

What is VTR's return on equity?

Ventas, Inc. (VTR) has a return on equity (ROE) of 2.1%. This is below average, suggesting room for improvement.

Industry Metrics
What is Ventas, Inc.'s FFO?

Ventas, Inc. (VTR) generated Funds From Operations (FFO) of $1.69B in the trailing twelve months. FFO is the primary profitability metric for REITs.

What if you invested $1,000 in VTR back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →